EPIRUS Biopharmaceuticals, Inc. Stock Split Ratio
EPIRUS Biopharmaceuticals, Inc. had Stock Split Ratio of 10.00% as of 2014-07-16, per its 10-K filed 2016-03-29.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2016-03-29
- 2014-07-16: Stockholders' Equity Note, Stock Split, Conversion Ratio 10.00%.
- 2013-10-03: Stockholders' Equity Note, Stock Split, Conversion Ratio 17.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 17.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month |
|---|---|---|
| 2014-07-16 | 10.00% 10-K · filed 2016-03-29 | |
| 2013-10-03 | 17.00% 10-Q · filed 2014-08-11 | 17.00% 10-Q · filed 2014-05-09 |